Get the Stockscreener App
2.10
0.47%
-0.010
After Hours:
2.11
0.010
+0.48%
Microbot Medical Inc stock is traded at $2.10, with a volume of 952.25K.
It is down -0.47% in the last 24 hours and down -12.50% over the past month.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
See More
Previous Close:
$2.11
Open:
$2.13
24h Volume:
952.25K
Relative Volume:
0.47
Market Cap:
$141.03M
Revenue:
-
Net Income/Loss:
$-13.14M
P/E Ratio:
-6.8717
EPS:
-0.3056
Net Cash Flow:
$-13.11M
1W Performance:
+0.00%
1M Performance:
-12.50%
6M Performance:
-0.94%
1Y Performance:
-16.00%
1-Day Range:
$2.09
$2.14
1-Week Range:
$2.03
$2.2099
52-Week Range:
$1.6001
$4.67
Microbot Medical Inc Stock (MBOT) Company Profile
Name
Microbot Medical Inc
Sector
Industry
Phone
908-938-5561
Address
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Compare MBOT vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBOT
Microbot Medical Inc
|
2.10 | 141.70M | 0 | -13.14M | -13.11M | -0.3056 |
ISRG
Intuitive Surgical Inc
|
451.38 | 160.21B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.62B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.32 | 37.37B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.45 | 35.82B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
207.88 | 30.38B | 5.40B | 1.49B | 1.78B | 10.12 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-26 | Initiated | B. Riley Securities | Buy |
| Dec-03-25 | Initiated | Roth Capital | Buy |
| Jan-13-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-24-19 | Reiterated | H.C. Wainwright | Buy |
| Jan-31-18 | Initiated | Ladenburg Thalmann | Buy |
Microbot Medical Inc Stock (MBOT) Latest News
Microbot Medical’s LIBERTY System Gains Early Market Traction - TipRanks
Microbot Medical®'s Liberty® endovascular robotic system is now adopted by multiple accounts across key territories including two Access-PVI pivotal clinical trial sites - marketscreener.com
A blood-vessel robot lands 2 trial sites as its rollout expands - Stock Titan
Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites - TradingView
Microbot wins multiple LIBERTY system accounts, including two ACCESS-PVI trial sites - TradingView
Microbot Medical (MBOT) gains new LIBERTY robotic adopters post-SIR - Stock Titan
Microbot Medical®’s LIBERTY® Endovascular Robotic System is - GlobeNewswire
Microbot Medical (NASDAQ:MBOT) Cut to "Strong Sell" at Wall Street Zen - MarketBeat
Microbot Medical Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia - marketscreener.com
MBOT Stock Price, Quote & Chart | MICROBOT MEDICAL INC (NASDAQ:MBOT) - ChartMill
Microbot Medical Inc. appoints Alon Tamir as VP Sales EMEA - Indian Pharma Post
Microbot Medical Expands EMEA Leadership for Global Growth - TipRanks
Microbot Medical appoints VP Sales EMEA to drive international commercial readiness - TradingView
Microbot Medical appoints Alon Tamir as VP of sales for EMEA - Investing.com UK
Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA) - The Manila Times
Microbot Medical (NASDAQ: MBOT) targets EMEA growth with new VP - Stock Titan
Microbot Medical (MBOT) price target increased by 12.50% to 7.65 - MSN
MBOT Technical Analysis | Trend, Signals & Chart Patterns | MICROBOT MEDICAL INC (NASDAQ:MBOT) - ChartMill
MBOT Earnings History & Surprises | EPS & Revenue Results | MICROBOT MEDICAL INC (NASDAQ:MBOT) - ChartMill
Microbot Medical Inc. (NASDAQ:MBOT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Microbot Medical begins full US launch of LIBERTY system - MSN
Microbot Medical | 8-K: Current report - Moomoo
Microbot Medical | 4: Statement of changes in beneficial ownership of securities-Director Burell Scott R - Moomoo
Microbot Medical (MBOT) Competitive Edge | Q4 2025: Profit Exceeds ViewsMarket Share - Cổng thông tin điện tử tỉnh Lào Cai
MBOT (Microbot Medical Inc.) reports narrower Q4 2025 loss than consensus estimates, shares fall more than two percent.High Interest Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
Microbot Medical Highlights Guidelines Supporting LIBERTY Robotic System - TipRanks
Microbot Medical welcomes updated SIR/CIRSE occupational guidelines, cites potential boost to LIBERTY commercial position - TradingView
Radiology safety push may aid Microbot (NASDAQ: MBOT) LIBERTY - Stock Titan
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY - ChartMill
Attachment - GlobeNewswire
How to Manage Microbot Medical (MBOT) Stock Risk (Modest Decline) 2026-04-20Hot Community Stocks - UBND thành phố Hải Phòng
HC Wainwright Analysts Increase Earnings Estimates for MBOT - MarketBeat
Microbot Medical to present at Needham healthcare conference By Investing.com - Investing.com Australia
Microbot Medical Begins Full U.S. Launch of LIBERTY System - Yahoo Finance
Microbot Medical® to Highlight Commercial Achievements Leading t - GuruFocus
Microbot Medical to Highlight Commercial Achievements Leading to the Full Market Release of the LIBERTY Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference - marketscreener.com
Microbot Medical® to Highlight Commercial Achievements - GlobeNewswire
MBOT Reiterated by HC Wainwright & Co. -- Price Target Maintained at $12 - GuruFocus
Microbot Medical to present at Needham healthcare conference - Investing.com
Microbot Medical to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference - Bitget
Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference - GlobeNewswire
Microbot Showcases LIBERTY Robotic System Full Release - TipRanks
Microbot to Spotlight LIBERTY Full Market Release, CEO to Present at Needham Conference - TradingView
Microbot Medical (NASDAQ: MBOT) to spotlight LIBERTY robotic system FMR - Stock Titan
Microbot Medical Inc Stock (MBOT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.78%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):